ArticleArthritis research & therapy2022

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial.

John K Botson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.